12.33

1.12% -0.14

After Hours: 12.33

Quanterix Corp (QTRX)

Overview News Price History Option Chain Financials Discussions Forecast

Quanterix Corp stock is traded at $12.33, with a volume of 93,008. It is down -1.12% in the last 24 hours and down -6.52% over the past month. Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

Previous Close:

$12.47

Open:

$12.55

24h Volume:

93,008

Relative Volume:

0.24

Market Cap:

$473.21M

Revenue:

$121.14M

Net Income/Loss:

$-32.33M

P/E Ratio:

-6.9661

EPS:

-1.77

Net Cash Flow:

$-22.69M

1W Performance:

+4.94%

1M Performance:

-6.52%

6M Performance:

-23.79%

1Y Performance:

-48.65%

1-Day Range:

$12.19

$12.55

1-Week Range:

$11.95

$12.61

52-Week Range:

$10.50

$29.70

Quanterix Corp Stock (QTRX) Company Profile

Name

Quanterix Corp

Sector

Healthcare (1180)

Industry

Medical Devices (148)

Phone

617-301-9400

Address

900 MIDDLESEX TURNPIKE, BILLERICA, MA

Employee

141

Twitter

@QuanterixSimoa

Next Earnings Date

2024-11-04

Latest SEC Filings

QTRX's Discussions on Twitter

Compare QTRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
QTRX Quanterix Corp	12.33	473.21M	121.14M	-32.33M	-22.69M	-0.86
ABT Abbott Laboratories	118.77	206.00B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	392.15	149.49B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.66	133.62B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	86.54	110.97B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	71.35	42.08B	6.60B	4.16B	490.10M	6.93

Quanterix Corp Stock (QTRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-01-24	Initiated	Scotiabank	Sector Outperform
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform
May-23-23	Upgrade	Goldman	Neutral → Buy
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-02-22	Upgrade	Goldman	Sell → Neutral
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell

View All

Quanterix Corp Stock (QTRX) Latest News

Nov 28, 2024

Quanterix Co. (NASDAQ:QTRX) Shares Acquired by Algert Global LLC - MarketBeat

Nov 28, 2024

Nov 26, 2024

QTRX (Quanterix) Growth Rank : 8 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Nov 24, 2024

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.

Nov 24, 2024

Nov 22, 2024

Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action InvestigationQTRX - PR Newswire

Nov 22, 2024

Quanterix Announces Receipt of Expected Notice from Nasdaq - Yahoo Finance

Nov 22, 2024

Nov 16, 2024

Quanterix Investors are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations - The Globe and Mail

Nov 16, 2024

Nov 15, 2024

Quanterix is Being Investigated for Potential Securities Law ViolationsContact Kaplan Fox & Kilsheimer LLP - The Globe and Mail

Nov 15, 2024

Q3 Earnings Forecast for Quanterix Issued By Leerink Partnrs - MarketBeat

Nov 15, 2024

Quanterix Co. (NASDAQ:QTRX) Short Interest Update - MarketBeat

Nov 15, 2024

Nov 14, 2024

Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Quanterix Corp (QTRX) - The Globe and Mail

Nov 14, 2024

Kaplan Fox & Kilsheimer LLP is Investigating Quanterix Corp (QTRX) for Potential Securities Law Violations - The Globe and Mail

Nov 14, 2024

Quanterix stock target raised to $16 on solid revenue growth - Investing.com India

Nov 14, 2024

Nov 13, 2024

Quanterix stock target raised to $16 on solid revenue growth By Investing.com - Investing.com Canada

Nov 13, 2024

Earnings call: Quanterix reports growth with focus on neurology and diagnostics - Investing.com

Nov 13, 2024

Portolan Capital Management, LLC Increases Stake in Quanterix Co - GuruFocus.com

Nov 13, 2024

Quanterix earnings beat, revenue topped estimates - Investing.com

Nov 13, 2024

Quanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024